SYNOSIA THERAPEUTICS

synosia-therapeutics-logo

Synosia Therapeutics develops and intends to commercialise products for unmet medical needs in psychiatry and neurology. The privately-owned company has in its pipeline six clinical-stage compounds acquired through partnerships with Novartis, Roche and Syngenta. Two of the compounds are marketed drugs being tested in new indications to extend their reach into neurological and psychiatric diseases with high unmet medical need, including anxiety and Parkinson's disease.

#SimilarOrganizations #People #Financial #Website #More

SYNOSIA THERAPEUTICS

Industry:
Biotechnology Medical Therapeutics

Founded:
2006-01-01

Address:
Basel, Basel-Stadt, Switzerland

Country:
Switzerland

Website Url:
http://www.synosia.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
94 M USD

Technology used in webpage:
SPF Amazon Amazon Ohio Region NameBright


Similar Organizations

boston-therapeutics-logo

Boston Therapeutics

Boston Therapeutics develops and commercializes novel compoundsย for unmet medical needs in the areas of diabetes and inflammatory diseases.

connetics-logo

Connetics

Connetics Corporation engages in the development and commercialization of products for the medical dermatology market.


Current Advisors List

genghis-lloyd-harris_image

Genghis Lloyd-Harris Board of Directors @ Synosia Therapeutics
Board_member

kevin-forrest_image

Kevin Forrest Board Observer @ Synosia Therapeutics
Board_observer

Current Employees Featured

not_available_image

Philippe Lutz
Philippe Lutz CFO @ Synosia Therapeutics
CFO

ian-j-massey_image

Ian J. Massey
Ian J. Massey CEO & President @ Synosia Therapeutics
CEO & President

Investors List

swiss-helvetia-fund_image

Swiss Helvetia Fund

Swiss Helvetia Fund investment in Series C - Synosia Therapeutics

aravis-ventures_image

Aravis Ventures

Aravis Ventures investment in Series C - Synosia Therapeutics

5am-ventures_image

5AM Ventures

5AM Ventures investment in Series C - Synosia Therapeutics

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series C - Synosia Therapeutics

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series C - Synosia Therapeutics

ucb-pharma_image

UCB

UCB investment in Series C - Synosia Therapeutics

investor-growth-capital_image

Investor Growth Capital Limited

Investor Growth Capital Limited investment in Series C - Synosia Therapeutics

swiss-helvetia-fund_image

Swiss Helvetia Fund

Swiss Helvetia Fund investment in Series B - Synosia Therapeutics

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series B - Synosia Therapeutics

abingworth-management_image

Abingworth

Abingworth investment in Series B - Synosia Therapeutics

Official Site Inspections

http://www.synosia.com

  • Host name: ec2-52-20-84-62.compute-1.amazonaws.com
  • IP address: 52.20.84.62
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Synosia Therapeutics" on Search Engine